SJ Investment Partners

SJ Investment Partners is a venture capital firm based in Seoul, South Korea, founded in 2010. The firm specializes in early-stage investments across various sectors, including information and communication technology, biotechnology, food, proptech, fintech, healthcare, gaming, materials, and tourism. Additionally, SJ Investment Partners manages the SJ Social Impact Bio Venture Fund, which focuses on environmentally sustainable and impactful investments in health-related areas. Through its diversified investment strategy, the firm aims to foster innovation and support the growth of promising companies within these industries.

Ok Jin-woo

Director

Sangmin Kim

Managing Director

25 past transactions

CloudHospital

Seed Round in 2022
CloudHospital, founded in Seoul, South Korea, operates an online platform designed to assist patients in locating the best medical providers globally. The platform enables users to compare healthcare professionals' services and fees, simplifying the search for appropriate medical solutions, whether for complex surgeries or routine checkups. With a commitment to connecting patients with top-tier hospitals and clinics, CloudHospital facilitates access to experienced doctors across various specialties. The services are available in multiple languages, including English, Chinese, and Russian, ensuring a wide reach. Additionally, CloudHospital supports its users with 24/7 customer service, enhancing the overall experience for patients seeking medical care worldwide.

S-Alpha Therapeutics

Series A in 2021
S-Alpha Therapeutics Inc. is a digital therapeutics company based in Seoul, South Korea, founded in 2019. The company focuses on researching and developing health applications and platform technologies aimed at treating a variety of diseases. Its product lineup includes SAT-001, an application for eye disease; SAT-002, designed for neurological conditions; SAT-003, which aids in cancer recovery and treatment; and SAT-008, a public crisis application addressing social issues. In addition to these applications, S-Alpha Therapeutics also develops therapeutic devices that support its digital health solutions. The company aims to provide innovative treatment methods for areas such as ophthalmology, neuropsychiatry, cancer, and immunology, addressing unmet medical needs through digital approaches.

Poen

Series A in 2021
Poen is a venture company of hyundai motors that focuses on battery upcycling using technology.

Mezoo

Series A in 2021
Developer of biomedical sensor technology designed to improve human race health by providing accurate diagnoses. The company's technology offers a small-sized, patch-type electrocardiogram that is attached to the test subject's chest and checks in real-time, enabling physicians to manage and prevent heart disease in patients.

S-Alpha Therapeutics

Seed Round in 2020
S-Alpha Therapeutics Inc. is a digital therapeutics company based in Seoul, South Korea, founded in 2019. The company focuses on researching and developing health applications and platform technologies aimed at treating a variety of diseases. Its product lineup includes SAT-001, an application for eye disease; SAT-002, designed for neurological conditions; SAT-003, which aids in cancer recovery and treatment; and SAT-008, a public crisis application addressing social issues. In addition to these applications, S-Alpha Therapeutics also develops therapeutic devices that support its digital health solutions. The company aims to provide innovative treatment methods for areas such as ophthalmology, neuropsychiatry, cancer, and immunology, addressing unmet medical needs through digital approaches.

Alsemy

Seed Round in 2020
Developer of semiconductor design platform designed to provide machine learning-based automated modeling technology. The company's platform leverages artificial intelligence technology to develop a program that can simulate providing a model to self-learn from data collected, enabling enterprises to fasten the development period and avoid errors that may occur in the design stage.

Cookat

Series C in 2019
Developer of a food blogging platform designed to deliver new information regarding unique food recipes based on a variety of food photos and videos. The company's platform is optimized for mobile phone users which lets them present food video content on social media, enabling consumers to buy wholesale items such as restaurant advertisements and home snacks (HMR) and sell them to other consumers as well.

House of Rebels

Series A in 2019
Operator of an intellectual property-commerce group intended to expand media and brands. The company media platform promotes creative works, building events, products, and brands in collaboration with a number of artists and creators, mostly from the subculture scene, enabling users to explore different cultures and brands.

AIONCO KOREA Co

Venture Round in 2019
AIONCO KOREA Co., Ltd., founded in 2015 and headquartered in Seoul, South Korea, specializes in global air freight and logistics services. The company offers a range of solutions, including fulfillment services, drop shipments, and global wholesale logistics, catering primarily to cross-border eCommerce clients. AIONCO KOREA is known for its comprehensive Multi-Channel Fulfillment solutions, which streamline the supply chain for both direct-to-consumer and wholesale businesses. Their services encompass planning and implementation, warehousing, distribution logistics, and storage, ensuring efficient handling of products from pallets to elegantly packaged deliveries.

Bomapp

Series A in 2019
Bomapp Inc., founded in 2015 and based in Seoul, South Korea, is a leading insurtech company that develops and operates the Bomapp application, an integrated mobile insurance manager. The app aims to simplify the insurance experience for users by offering features such as personalized coverage reports through its “Bomapp Coverage Fitting” service, as well as tools for current policy lookup, easy claims, and complimentary public insurance information. With over 2.2 million downloads and 1.7 million registered users as of July 2020, Bomapp seeks to engage a wider audience in the insurance market. In addition to its business-to-consumer offerings, the company is expanding into business-to-business and business-to-business-to-consumer sectors, addressing the insurance needs of small and medium-sized enterprises and platform service providers. Bomapp's mission is to enhance the digital insurance landscape by providing a seamless, user-friendly experience that allows consumers to compare and apply for insurance coverage easily and at more competitive rates.

Inventage Lab

Seed Round in 2018
Inventage Lab Inc. focuses on the advancement of medical technology, particularly through the development of an innovative Drug Delivery System (DDS). The company has created Laminar FluiDigm, a microfluidics-based platform technology that underpins its specific technologies, IVL-DrugFluidic and IVL-GeneFluidic, which are designed for the development and manufacture of long-acting injectables and gene-delivery therapeutics. In addition to its medical initiatives, Inventage Lab is committed to creating consumer-oriented pipelines aimed at enhancing human well-being and fostering technological innovation. Through these efforts, the company seeks to improve treatment options for refractory and chronic diseases while contributing to advancements in healthcare.

Tripbtoz

Seed Round in 2018
Tripbtoz, Inc. owns and operates an online hotel booking platform. It offers social travel platform that enables user to shoot and share travel videos. Tripbtoz, Inc. was founded in 2015 and is based in Seoul, South Korea.

Todoc

Series A in 2018
Todoc is a technology leader in the field of neural prosthesis and neuromodulation in Korea, specializing in the development of advanced cochlear implant systems. The company aims to address the high costs associated with cochlear implants, which have traditionally limited access to hearing restoration for individuals in developing countries. Todoc's innovative approach involves automated micro-machining processes to manufacture neural electrodes, significantly reducing production costs to one-tenth of conventional methods. This advancement not only makes cochlear implants more affordable but also enhances their performance by offering a wider range of sound capabilities. The company's 32-channel cochlear implant system stands out with the highest number of channels available, utilizing wireless transmission technology for effective data transfer. Todoc's mission is to expand the global cochlear implant market and establish itself as a leader in the Brain-Machine Interface sector through its superior neural interface technology.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.